title: Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer.
abstract: Research suggests that exposure to ambient particulate matter (PM) may be associated with lung cancer; however, no mode of action (MoA) for this has been established. We applied a weight-of-evidence (WoE) approach to evaluate recent evidence from four realms of research (controlled human exposure, epidemiology, animal, and in vitro) to determine whether the overall evidence supports one or more MoAs by which PM could cause lung cancer. We evaluated three general MoAs: DNA damage and repair; other genotoxic effects, including mutagenicity and clastogenicity; and gene expression, protein expression, and DNA methylation. After assessing individual study quality, we evaluated the strength of the evidence within as well as across disciplines using a modified set of Bradford Hill considerations. We conclude that the overall WoE indicates it is plausible that PM of various size fractions may cause direct DNA damage, but the evidence is insufficient regarding the alternative MoAs we evaluated. More research is needed to determine whether DNA damage can lead to downstream events and, ultimately, lung cancer.
authors.affiliation: Gradient, 20 University Road, Cambridge, MA 02138, USA.
authors.forename: H N
authors.initials: HN
authors.lastname: Lynch
authors.affiliation: Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, 4225 Roosevelt Way NE, Suite 301 Seattle WA 98105, USA.
authors.forename: C T
authors.initials: CT
authors.lastname: Loftus
authors.affiliation: Gradient, 600 Stewart Street, Suite 1900, Seattle, WA 98101, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Cohen
authors.affiliation: Gradient, 20 University Road, Cambridge, MA 02138, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Kerper
authors.affiliation: Gradient, 20 University Road, Cambridge, MA 02138, USA.
authors.forename: E M
authors.initials: EM
authors.lastname: Kennedy
authors.affiliation: Gradient, 20 University Road, Cambridge, MA 02138, USA. Electronic address: jgoodman@gradientcorp.com.
authors.forename: J E
authors.initials: JE
authors.lastname: Goodman
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D004249:DNA Damage; D019175:DNA Methylation / Q000187:drug effects; D004260:DNA Repair / Q000187:drug effects; D004781:Environmental Exposure / Q000009:adverse effects*; D004785:Environmental Pollutants / Q000009:adverse effects*; D004812:Epidemiologic Methods; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000235:genetics* / Q000378:metabolism; D023421:Models, Animal; D016296:Mutagenesis; D052638:Particulate Matter / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D018675:Toxicity Tests
chemical_list: D014408:Biomarkers, Tumor; D004785:Environmental Pollutants; D052638:Particulate Matter
keywords: Cancer biomarkers; Lung cancer; Mechanism of action; Particulate matter; Weight of evidence